-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Traws Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
- Traws Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.54M, a 67.7% decline year-over-year.
- Traws Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$142M, a 556% decline year-over-year.
- Traws Pharma, Inc. annual Operating Income (Loss) for 2023 was -$20.3M, a 3.42% decline from 2022.
- Traws Pharma, Inc. annual Operating Income (Loss) for 2022 was -$19.6M, a 19% decline from 2021.
- Traws Pharma, Inc. annual Operating Income (Loss) for 2021 was -$16.5M, a 34% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)